(Q44210726)

30 November 2017

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning (English)

1 reference

30 November 2017

13

Ulrich Germing

1 reference

30 November 2017

14

Norbert Gattermann

1 reference

30 November 2017

Brigitte Royer-Pokora

11

object named as

Brigitte Royer-Pokora

1 reference

30 November 2017

Guido Kobbe

1

1 reference

30 November 2017

Peter Schneider

2

1 reference

30 November 2017

Manuel Aivado

3

1 reference

30 November 2017

Fabian Zohren

4

1 reference

30 November 2017

Dominique Schubert

5

1 reference

30 November 2017

Roland Fenk

6

1 reference

30 November 2017

Frank Neumann

7

1 reference

30 November 2017

Ralf Kronenwett

8

1 reference

30 November 2017

Hildegard Pape

9

1 reference

30 November 2017

Astrid Rong

10

1 reference

30 November 2017

Barbara Hildebrandt

12

1 reference

30 November 2017

Axel Heyll

15

1 reference

30 November 2017

Rainer Haas

16

1 reference

30 November 2017

1 November 2002

1 reference

30 November 2017

Experimental Hematology

1 reference

30 November 2017

30

1 reference

30 November 2017

11

1 reference

30 November 2017

1346-1353

1 reference

Bone-marrow transplantation (first of two parts).

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Mixed chimerism: preclinical studies and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2900923-2

7 January 2021

10.1016/S0301-472X(02)00923-2

Identifiers

DOI

1 reference

30 November 2017

1 reference